Condition
Upper Urinary Tract Urothelial Carcinoma clinical trials and research
Research outlook What's coming for Bladder cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 6 Upper Urinary Tract Urothelial Carcinoma clinical trials that are recruiting, at sites in 13 countries (most in China (3), Denmark (1), Norway (1)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 13Countries
Newest Upper Urinary Tract Urothelial Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Danish Bladder Cancer Group 23: European effort on cancer in the upper urinary tract | — | Aarhus N and 4 other locations | Recruiting | Jul 22, 2025 |
| UGN-104 treatment for low-grade upper tract urothelial cancer | Phase 3 | Homewood, Alabama and 78 other locations | Recruiting | Jan 14, 2025 |
| Combining DV and Toripalimab for Kidney Preservation in Patients with Urothelial Carcinoma | Phase 2 | Shanghai | Recruiting | Apr 9, 2024 |
| Adjuvant disitamab vedotin plus radiotherapy for HER2‑overexpressing upper urinary tract urothelial carcinoma with high recurrence risk | Phase 2 | Beijing, Beijing Municipality | Recruiting | Jan 18, 2024 |
| Observing cancer relapse and quality of life after kidney surgery | — | Milan, MI | Recruiting | Dec 13, 2023 |
| Combining RC48 and Tislelizumab for kidney preservation in high-risk UTUC patients | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Jun 22, 2023 |
All recruiting trials (6)
-
Danish Bladder Cancer Group 23: European effort on cancer in the upper urinary tract
This project will see if kidney-sparing surgery can be used safely for adults with upper urinary tract urothelial carcinoma instead of removing the entire kidney and ureter.
-
UGN-104 treatment for low-grade upper tract urothelial cancer
This Phase 3 trial tests whether weekly UGN-104 instillations can clear low-grade upper tract urothelial cancer in patients with small papillary tumors in the renal pelvis.
-
Combining DV and Toripalimab for Kidney Preservation in Patients with Urothelial Carcinoma
This study is testing a new combination treatment of DV and toripalimab to see if it can help people with kidney problems and bladder cancer keep their kidneys while treating their cancer.
-
Adjuvant disitamab vedotin plus radiotherapy for HER2‑overexpressing upper urinary tract urothelial carcinoma with high recurrence risk
This study will try whether adding disitamab vedotin to radiotherapy after surgery helps people with HER2‑positive upper urinary tract urothelial carcinoma who are at high risk of recurrence.
-
Observing cancer relapse and quality of life after kidney surgery
This study looks at how kidney surgery affects cancer relapse and the overall quality of life for patients with a specific type of urinary tract cancer.
-
Combining RC48 and Tislelizumab for kidney preservation in high-risk UTUC patients
This study is testing a new combination of two treatments, RC48 and Tislelizumab, to see if they can help protect the kidneys in patients with high-risk upper urinary tract cancer.
Related topics
Quick answers
How many Upper Urinary Tract Urothelial Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in China (3 trials), Denmark (1 trial), Norway (1 trial), Italy (1 trial), Bulgaria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.